BioSyent Releases Financial Results for Q2 and H1 2026

MISSISSAUGA, Ontario, Aug. 20, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its consolidated financial results for the three months (Q2), six months (H1), and trailing twelve months (TTM) ended June 30, 2026.  Key highlights include:   (CAD) Q2 2026   % Changevs. Q2 2025   H1 2026   % Changevs. […]